Concorde Financial’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.07M | Sell |
32,705
-94
| -0.3% | -$17.4K | 3.59% | 11 |
|
2025
Q1 | $6.87M | Sell |
32,799
-98
| -0.3% | -$20.5K | 3.79% | 8 |
|
2024
Q4 | $5.85M | Buy |
32,897
+124
| +0.4% | +$22K | 3.48% | 10 |
|
2024
Q3 | $6.47M | Sell |
32,773
-420
| -1% | -$82.9K | 3.81% | 7 |
|
2024
Q2 | $5.69M | Sell |
33,193
-8,225
| -20% | -$1.41M | 3.74% | 9 |
|
2024
Q1 | $7.54M | Sell |
41,418
-70
| -0.2% | -$12.7K | 6.86% | 3 |
|
2023
Q4 | $6.43M | Buy |
41,488
+34,788
| +519% | +$5.39M | 4.4% | 5 |
|
2023
Q3 | $999K | Sell |
6,700
-34,038
| -84% | -$5.07M | 1.7% | 12 |
|
2023
Q2 | $5.49M | Sell |
40,738
-570
| -1% | -$76.8K | 3.59% | 9 |
|
2023
Q1 | $6.58M | Sell |
41,308
-581
| -1% | -$92.6K | 4.8% | 4 |
|
2022
Q4 | $5.62M | Hold |
41,889
| – | – | 3.79% | 6 |
|
2022
Q3 | $5.62M | Sell |
41,889
-81
| -0.2% | -$10.9K | 3.79% | 6 |
|
2022
Q2 | $6.43M | Sell |
41,970
-3,585
| -8% | -$549K | 7.18% | 3 |
|
2022
Q1 | $6.78M | Sell |
45,555
-1,282
| -3% | -$191K | 4.17% | 6 |
|
2021
Q4 | $6.33M | Buy |
+46,837
| New | +$6.33M | 3.98% | 5 |
|